10 May 2018
16 February 2018
Civil Society Speaks: Fighting for Universal Access To Dolutegravir (DTG)!
Source : The Global Network of People living with HIV GNP+ What do people living with HIV need to know about Dolutegravir? What do our communities need to know about viral resistance to first
8 February 2018
Global Fund MENA Regional Platform is relaunched
ITPC-MENA continues as the host for the Middle East and North Africa region As a key component of the Global Fund’s Community, Rights and Gender Strategic Initiative, the Regional Platform for Communication and Coordination
15 October 2017
ITPC-MENA organize its Middle East and North Africa Community Advisory board (MENACAB…
The International Treatment Preparedness Coalition in Middle East and North Africa (ITPC-MENA) is organizing its Middle East and North Africa Community Advisory board (MENACAB), in late November in Marrakech.The MENACAB is a treatment advocate network
21 September 2017
ITPC-MENA at the Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017)
ITPC-MENA at 2nd Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017) Join ITPC-MENA at AFRAMED 2017 – Hammamet Join ITPC_MENA at 2nd Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017) in Tunis and Hammamet from
14 September 2017
2nd Francophone Symposium AFRAMED on HIV and Hepatitis
2nd Francophone Symposium AFRAMED on HIV and Hepatitis September 28 to 30, Hammamet, Tunisie Following the success of the first experience in Algeria, the second edition of AFRAMED symposium will be hosted by Tunisia.
25 July 2017
A new victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on A…
The 9th International AIDS Society Conference on HIV / AIDS 2017 : Bristol-Myers Squibb extends its voluntary license on Atazanavir to Egypt, a victory for ITPC-MENA Today, at the World Conference on AIDS, which
25 July 2017
BLOG: We want dolutegravir for all, and we want it now
Source: makemedicinesaffordable Author: Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC). Article first published on the Huffington Post here. We’re calling for a compulsory license on
24 July 2017
HIV Activists Denounce ViiV for Denying 3.5 million People Access to Optimal Treatmen…
Source : ITPC GLOBAL Today, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment activists from around the world collectively blocked access to ViiV
21 July 2017